8-KEarnings & ResultsRegulation FDOther Events+1

HCA Healthcare, Inc. 8-K Report, Financial Results (Jul 23, 2024)

Filed July 23, 2024For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on July 23, 2024, primarily to disclose its second-quarter 2024 financial results via a press release. While the specific financial figures are detailed within the attached press release (Exhibit 99.1), the filing itself confirms the company is communicating its operational performance for the period ended June 30, 2024. In addition to the quarterly results, HCA Healthcare also announced a quarterly cash dividend of $0.66 per share. This dividend underscores the company's commitment to returning capital to shareholders and provides a concrete return for investors. The payment date is set for September 30, 2024, with a record date of September 16, 2024, offering investors a clear timeline for dividend receipt.

Key Highlights

  • 1HCA Healthcare announced its second-quarter 2024 financial results on July 23, 2024, through a press release (Exhibit 99.1).
  • 2The company's Board of Directors declared a quarterly cash dividend of $0.66 per share.
  • 3The dividend payment date is scheduled for September 30, 2024.
  • 4The record date for the dividend is September 16, 2024.
  • 5The 8-K filing serves as the official channel for disseminating these important financial and corporate actions.
  • 6Investors should refer to Exhibit 99.1 for detailed Q2 2024 financial performance metrics.

Frequently Asked Questions

The 8-K filing itself does not contain the detailed financial results. Investors need to refer to Exhibit 99.1, which is the press release dated July 23, 2024, attached to this filing for the comprehensive second-quarter financial performance of HCA Healthcare.

The Board of Directors declared a quarterly cash dividend of $0.66 per share. This dividend will be paid on September 30, 2024, to stockholders of record as of the close of business on September 16, 2024.

This particular 8-K filing primarily focuses on the disclosure of the second-quarter financial results and the declaration of the quarterly cash dividend. No other material events or business updates are detailed in the main body of the 8-K itself, beyond these announcements.